HCW Biologics announced a 1-for-6 reverse stock split effective June 30, 2026, to maintain compliance with Nasdaq's minimum bid price rule after its stock traded above $1.00 for 28 consecutive days. The reverse split will reduce the number of outstanding shares from about 9.58 million to approximately 1.6 million without changing shareholders' ownership percentages. This move follows a Nasdaq Hearings Panel decision requiring the company to keep its stock price above $1.00 or face delisting. The company's stock will continue trading under the symbol HCWB on a split-adjusted basis, and shareholders holding fractional shares will receive one whole share instead.
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Industrial Development Funding (IDF) and Oaktree have committed $1.7 billion to support Bloom Energy's fuel cell technology for building AI cloud infrastructure for Nebius. This project will provide dedicated behind-the-meter power to meet the high c...
